ZYME - FDA decision on Aug 25: opportunity or already priced in?

reddit_wallstreetbets · 2026-08-22 · Neutral AI sentiment

$ZYME

I’ve been looking at Zymeworks ($ZYME) ahead of the Aug 25 FDA PDUFA date for Ziihera (zanidatamab) in first-line HER2+ gastroesophageal adenocarcinoma. I’m relatively new to trading biotech catalysts, so I’m posting this mainly to have people poke holes in the thesis rather than to pitch the stock. The bull case as I understand it: - Ziihera already has strong Phase 3 data behind it. - FDA decision is due Aug 25. - Approval would trigger a $250M milestone payment to Zymeworks. - That’s pretty m

Read the original at reddit_wallstreetbets ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.